Taking Aspirin Shown To Improve Survival Rates In Nonmetastatic Colon And Rectal Cancer Patients
Taking Aspirin Shown to Improve Survival Rates in Non-Metastatic Colon and Rectal Cancer Patients
The researchers have several reasons to believe that aspirin was responsible for the improved survival. For example, researchers found that only tumors with high levels of COX-2 benefited from aspirin use. Aspirin is known to inhibit COX-2, which promotes inflammation and cell growth and is found at high levels in most colorectal cancers.
Based on the study results, if you have been diagnosed with non-metastatic colon cancer, it would be beneficial to talk to your doctor about the possibility of regular aspirin use, keeping in mind that not everyone should regularly use aspirin because of its side effects.